OakChart

Cerus Corp

CERSHealthcare·Medical Devices·USA·Small·NASD·Nov 11 • 3:59 PM ET

2.12+0.17 (8.72%)
2026-11-12 05:30 CET
Market cap
428.14 USD m
Revenue, TTM
226.57 USD m
Net income, TTM
-7.31 USD m
Free cash flow, TTM
0.33 USD m
EPS diluted, TTM
-0.04
P/E
-
Compare

Price

CERS against its 20, 50 and 200-day averages
2050200beatmiss
2.002.503.003.504.2M8.3MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CERSclose 2.1220-day 2.2750-day 2.38200-day 2.432.1252w high

38.9% under the 52-week high of 3.47 on 6 Jul 2026. 52-week low 1.47 on 21 Nov 2025. Last 15 sessions, 31.9% high to low

Volume 1.12× normal · the line is the 50-bar volume average

Profile

CERS
52-week range, 33% of the way up
1.473.47

Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

IndexRUT
Employees275
IPOJan 31, 1997
Beta1.87
ATR, 14d0.15
Rel volume1.12
Short float7.66%
Insider own5.38%
Inst own77.53%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap428.14M
Enterprise Value446.65M
Income-7.31M
Sales226.57M
Book/sh0.37
Cash/sh0.28
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees275
IPOJan 31, 1997

Ratios

P/E-
Forward P/E-
PEG-
P/S1.89
P/B5.65
P/C7.50
P/FCF1297.40
EV/EBITDA-
EV/Sales1.97
Quick Ratio1.15
Current Ratio1.96
Debt/Eq0.99
LT Debt/Eq0.57
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.04
EPS next Y0.00
EPS next Q-0.00
EPS this Y65.62%
EPS next Y100.00%
EPS next 5Y-
EPS past 3/5Y30.31% 25.82%
Sales past 3/5Y8.35% 17.53%
EPS Y/Y TTM56.08%
Sales Y/Y TTM13.74%
EPS Q/Q-2600.00%
Sales Q/Q9.52%
EarningsNov 02 AMC
EPS/Sales Surpr.100.00% 1.19%

Ownership

Insider Own5.38%
Insider Trans-2.57%
Inst Own77.53%
Inst Trans1.36%
ROA-3.48%
ROE-10.66%
ROIC-6.15%
Gross Margin51.45%
Oper. Margin-12.22%
Profit Margin-3.23%
SMA20-6.43%
SMA50-11.10%
SMA200-12.91%
Trades-

Technical

Shs Outstand201.89M
Shs Float191.08M
Short Float7.66%
Short Ratio7.35
Short Interest14.63M
52W High3.47 -38.90%
52W Low1.47 44.22%
Volatility10.47% 6.29%
ATR (14)0.15
RSI (14)42.64
Beta1.87
Rel Volume1.12
Avg Volume1.99M
Volume2,237,800

Performance

Perf Week-12.22%
Perf Month-6.19%
Perf Quarter-25.35%
Perf Half Y-18.46%
Perf YTD2.91%
Perf Year28.48%
Perf 3Y32.50%
Perf 5Y-71.00%
Perf 10Y-63.19%
Recom1.00
Target Price5.12
Prev Close1.95
Price2.12
Change %8.72%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
May 01, 2026UpgradeBBTIG ResearchNeutral → Buy$4+88.7%
Apr 12, 2024InitiatedCCraig HallumBuy$5+135.8%
Jan 20, 2023DowngradeBBTIG ResearchBuy → Neutral
Jan 17, 2023DowngradeSStephensOverweight → Equal-Weight$3.75+76.9%
Oct 08, 2020ResumedBBTIG ResearchBuy$9+324.5%
Jun 16, 2020ResumedCCantor FitzgeraldOverweight$9+324.5%
Feb 26, 2020InitiatedBBTIG ResearchBuy$7+230.2%
Nov 13, 2019UpgradeBBTIG ResearchNeutral → Buy$7+230.2%
Aug 28, 2019InitiatedSStifelBuy
Aug 23, 2019ResumedSStephensOverweight

Peers

Mkt cap
TickerCompanyMkt cap
HAEHaemonetics Corp5.49B
QDELQuidelOrtho Corp817.18M
CTSOCytosorbents Corp16.83M
GRFSGrifols SA ADR2.28B
ADMAAdma Biologics Inc2.93B
ICUIICU Medical Inc4.46B
KMDAKamada Ltd469.02M
BAXBaxter International Inc13.63B
BDXBecton Dickinson & Co58.43B
NEPHNephros Inc33.37M

Insider trading

latest 14 of 32
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Jensen ChrystalChief Legal OfficerAug 17 '26Sale2.9830,00089,529936,657Aug 17 08:18 PM
CHRYSTAL NIKOLE JENSENOfficerAug 17 '26Proposed Sale2.9830,00089,529Aug 17 04:39 PM
Jayaraman Vivek KChief Executive OfficerJul 16 '26Sale3.1616,66652,6652,232,211Jul 20 05:03 PM
VIVEK K JAYARAMANOfficerJul 16 '26Proposed Sale3.1616,66652,665Jul 16 04:15 PM
Green Kevin DennisChief Financial OfficerJun 30 '26Sale2.9433,67699,1051,062,188Jul 02 07:19 PM
Jayaraman Vivek KChief Operating OfficerJun 30 '26Sale2.9442,359124,6581,694,348Jul 02 07:18 PM
Jensen ChrystalChief Legal OfficerJun 30 '26Sale2.9424,32971,598966,657Jul 02 07:15 PM
Greenman William MarinerPresident and CEOJun 30 '26Sale2.94101,919299,9375,053,036Jul 02 07:13 PM
BJERKHOLT ERICDirectorJun 09 '26Sale2.6020,45453,180261,679Jun 11 09:17 PM
ERIC BJERKHOLTDirectorJun 09 '26Proposed Sale2.6020,45453,180Jun 09 04:12 PM
Jayaraman Vivek KChief Operating OfficerMay 29 '26Sale3.0016,66750,0011,656,707Jun 02 07:46 PM
VIVEK K JAYARAMANOfficerMay 29 '26Proposed Sale3.0016,66750,001May 29 04:13 PM
Jayaraman Vivek KChief Operating OfficerMay 01 '26Sale3.0016,66750,0011,673,374May 05 06:31 PM
RICHARD J BENJAMINOfficerMay 01 '26Proposed Sale2.8276,209214,627May 01 04:08 PM

Held by

AUM
TickerCompanyAUM
ARKEARK DIET Q3 Buffer ETFAUM: 1.45M
ARKKARK Innovation ETFAUM: 5.97B
ARKGARK Genomic Revolution ETFAUM: 1.97B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.82B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B

News

latest 14 of 100

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-020.000-0.0130.00064.0063.254
2026Q22026-07-30-0.010-0.013-0.01563.3062.903
2026Q12026-04-30-0.010-0.040-0.00859.9055.683
2025Q42026-03-02-0.010-0.008-0.01164.6061.834
2025Q32025-11-060.000-0.0280.00060.2057.794
2025Q22025-08-05-0.030-0.028-0.03060.1054.374
2025Q12025-05-01-0.040-0.040-0.04148.9049.614
2024Q42025-02-20-0.010-0.012-0.01456.7554.395
2024Q32024-10-30-0.020-0.032-0.01650.6650.825
2024Q22024-08-01-0.030-0.042-0.03150.5247.635
2024Q12024-05-02-0.050-0.048-0.05343.4043.235
2023Q42024-03-05-0.010-0.028-0.00753.3453.574
2023Q32023-11-02-0.040-0.053-0.04047.3048.743
2023Q22023-08-02-0.070-0.058-0.07447.7047.654
2023Q12023-05-04-0.090-0.083-0.08838.4838.403
2022Q42023-02-28-0.080-0.056-0.07751.3249.164

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-0.510-0.507-0.51093.7692.59
2020FY-0.370-0.367-0.36511091.90
2021FY-0.320-0.345-0.318159.52149.11
2022FY-0.240-0.217-0.242188.32186.16
2023FY-0.210-0.223-0.208186.8187.01
2024FY-0.110-0.112-0.113201.32198.96
2025FY-0.080-0.080-0.080233.8231.03
2026FY--0.028--255
2027FY-0.000--277.05
2028FY-0.030--303.85
2029FY-0.000--336
2030FY-0.000--366

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0340167.8266.9068.90
2026Q4S2026-11-0240068.1367.5069.00
2026Q4S2026-10-2440068.1367.5069.00
2026Q4S2026-10-1441068.1367.5069.00
2026Q4S2026-08-1842068.1367.5069.00
2026Q4S2026-08-1332067.8367.5068.30
2026Q4S2026-08-1022068.0067.7068.30
2026Q4S2026-08-0911067.7067.7067.70
2026Q4S2026-07-3131067.0265.8067.70
2026Q4S2026-07-1530066.5265.8067.57
2026Q4S2026-05-0130266.5265.8067.57
2026Q4S2026-03-1030068.2366.7070.80
2026Q4S2026-03-0320066.9466.7067.18
2026Q4S2026-02-1330067.1766.6067.50

Estimate history

EPS, annual-0.56-0.437-0.51-0.365-0.318-0.242-0.208-0.113-0.082-0.0372
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.016-0.014-0.041-0.030-0.011-0.008-0.015-0.003
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual51.32676.05193.77491.92130.859162.048156.367180.27206.133226.57
Period201720182019202020212022202320242025TTM
Sales, quarterly46.01750.80943.23952.44552.69857.75153.66157.44157.714
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual115.555136.853144.291168.17173.67177.582181.248185.766192.142201.887
Period201720182019202020212022202320242025MRQ
Shares, quarterly185.626185.766191.114191.588192.037192.142200.316201.457201.887
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue226.57206.13180.27156.37162.05130.8691.9293.7776.05
Cost of Goods Sold Incl. D&A110.0195.8482.7572.3777.4565.9743.3635.6232.73
Gross Profit116.56110.2997.5284.0084.5964.8848.5658.1643.32
Selling, General and Administrative Excl. Other144.25146.63132.80140.75144.94142.48128.93124.3898.31
Research and Development58.7065.7256.9165.2461.6161.1962.2158.1841.46
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-27.70-36.35-35.28-56.76-60.35-77.59-80.36-66.23-54.99
Interest Expense6.798.348.888.395.834.923.753.964.01
Unusual Expense0.000.000.003.730.57-0.150.302.100.00
Net Income Before Taxes-7.02-15.28-20.76-37.32-42.34-54.06-59.57-70.98-57.34
Income Taxes0.370.350.200.330.490.320.280.260.23
Consolidated Net Income-7.39-15.64-20.96-37.65-42.83-54.38-59.86-71.24-57.56
Net Income From Continuing Operations-7.31-15.63-20.92-37.49-42.78-54.37-59.86-71.24-57.56
Net Income-7.31-15.63-20.92-37.49-42.78-54.37-59.86-71.24-57.56
EPS (Recurring)-0.04-0.08-0.11-0.19-0.24-0.32-0.36-0.50-0.44
EPS (Basic, Before Extraordinaries)-0.04-0.08-0.11-0.21-0.24-0.32-0.37-0.51-0.44
EPS (Diluted)-0.04-0.08-0.11-0.21-0.24-0.32-0.37-0.51-0.44
EBITDA-25.26-34.35-33.28-54.35-55.79-73.03-75.91-63.82-53.54
Non-Operating Income (Expense)27.4629.4123.4031.5524.4128.3124.841.311.66
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense16.9218.0618.0616.0119.32-17.2113.1610.528.21
Price To Sales Ratio2.121.901.582.493.988.9112.346.298.78
Gross Margin51.4553.5054.1053.7252.2049.5852.8362.0256.96
Operating Margin-12.22-17.63-19.57-36.30-37.24-59.30-87.43-70.62-72.30
Net Margin-3.23-7.58-11.60-23.98-26.40-41.55-65.12-75.97-75.69
Shares Outstanding201.89192.14185.77181.25177.58173.67168.17144.29136.85
Market Capitalization428.14428.14286.00391.39647.591,173.131,156.62592.16687.94

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue57.7157.4453.6657.7552.7052.4543.2450.81
Cost of Goods Sold Incl. D&A27.8728.3725.7728.0024.5623.4717.8223.42
Gross Profit29.8429.0727.8929.7528.1428.9825.4227.39
Selling, General and Administrative Excl. Other35.7736.7934.4837.2234.4440.0836.8934.78
Research and Development13.8513.9314.5316.3915.8218.9016.6115.44
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-5.92-7.72-6.59-7.47-6.30-11.11-11.47-7.39
Interest Expense1.241.711.871.962.122.152.112.05
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-0.51-2.89-1.56-2.060.07-5.64-7.64-2.45
Income Taxes0.070.100.090.120.090.080.070.11
Consolidated Net Income-0.58-2.98-1.65-2.18-0.02-5.71-7.72-2.56
Net Income From Continuing Operations-0.55-2.94-1.64-2.18-0.02-5.71-7.72-2.52
Net Income-0.55-2.94-1.64-2.18-0.02-5.71-7.72-2.52
EPS (Recurring)-0.00-0.01-0.01-0.01-0.00-0.03-0.04-0.01
EPS (Basic, Before Extraordinaries)-0.00-0.01-0.01-0.01-0.00-0.03-0.04-0.01
EPS (Diluted)-0.00-0.01-0.01-0.01-0.00-0.03-0.04-0.01
EBITDA-5.50-7.26-6.14-6.36-5.92-10.76-11.16-6.29
Non-Operating Income (Expense)6.646.556.907.378.497.625.936.99
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense4.824.343.873.894.444.495.244.35
Price To Sales Ratio2.122.641.631.921.531.401.401.59
Gross Margin51.7150.6151.9851.5153.4055.2558.8053.90
Operating Margin-10.26-13.44-12.27-12.93-11.96-21.18-26.52-14.55
Net Margin-0.95-5.12-3.06-3.78-0.04-10.88-17.85-4.96
Shares Outstanding201.89201.46200.32192.14192.04191.59191.11185.77
Market Capitalization428.14585.08349.75395.70304.80269.54258.25286.00

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments82.8880.4565.85102.15129.36133.5985.72117.5860.70
Short Term Receivables30.3729.7835.5034.4325.1323.5518.6810.5312.62
Inventories56.1038.1539.8729.0026.7923.2519.4913.5414.46
Other Current Assets5.033.643.224.565.823.044.225.262.13
Total Current Assets174.38152.02144.44170.14187.10183.43128.11146.9089.90
Net Property, Plant & Equipment19.3315.5419.3523.4825.1826.9929.028.132.12
Total Investments and Advances0.641.091.711.772.852.312.442.730.25
Intangible Assets1.321.321.321.321.321.321.451.651.85
Other Assets26.1930.9530.9321.3821.057.374.524.054.13
Total Assets221.86200.92197.75218.09237.50221.41165.53163.4698.24
Short Term Debt Incl. Current Port. of LT Debt46.2521.5722.4558.2616.6010.436.637.860.00
Accounts Payable28.0121.7023.8433.0035.6124.2122.1818.5910.97
Other Current Liabilities26.5520.3421.2325.7926.3525.3321.5226.2312.16
Total Current Liabilities100.8063.6167.52117.0678.5659.9750.3452.6823.13
Long Term Debt50.7076.5373.5528.9770.9856.4657.8222.0129.80
Provision for Risks Charges0.000.000.001.900.000.000.000.000.00
Other Liabilities5.393.893.241.602.341.170.334.256.38
Total Liabilities156.89144.02144.30149.53151.88117.61108.4878.9459.30
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity64.2256.1552.6567.6184.62103.8157.0584.5238.94
Total Shareholders Equity64.2256.1552.6567.6184.62103.8157.0584.5238.94
Accumulated Minority Interest0.740.750.790.951.000.000.000.000.00
Total Equity64.9756.9053.4468.5685.62103.8157.0584.5238.94
Total Liabilities & Stockholders Equity221.86200.92197.75218.09237.50221.41165.53163.4698.24
Book Value Per Share0.330.300.290.380.490.620.400.620.34
Tangible Book Value Per Share0.330.300.280.370.480.610.390.610.32
Full-Time Employees275281288309294270254240215
Price to Book Ratio5.655.348.138.8613.9811.2110.678.2110.37
Return on Assets-7.39-10.49-18.03-18.78-23.70-30.94-43.31-43.99-60.07
Return on Equity-25.97-38.45-62.35-56.20-57.71-74.42-100.65-93.25-125.27
Return on Invested Capital-13.60-15.77-29.71-44.29-34.94-37.35-62.02-54.03-88.14
Quick Ratio1.171.791.551.212.042.672.162.533.26
Current Ratio1.732.392.141.452.383.062.552.793.89

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-7.39-15.64-20.96-37.65-42.83-54.38-59.86-71.24-57.56
Depreciation1.721.431.852.604.564.574.462.401.45
Other Funds (Non Cash)24.2625.8825.2323.9128.7025.2818.5915.2911.65
Funds from Operations18.5911.676.13-11.13-9.56-24.52-36.81-53.55-44.47
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-15.26-6.835.23-32.03-16.05-9.40-3.93-12.2913.22
Cash from Operating Activities3.334.8411.36-43.17-25.61-33.92-40.74-65.84-31.25
Capital Expenditures-3.00-3.73-2.84-4.60-2.00-0.91-1.61-8.94-1.14
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.001.000.000.000.00
Purchase or Sale of Investments20.94-2.44-5.2913.2210.4613.60-47.9437.12-42.70
Purchase of Investments-39.19-42.78-42.98-2.49-29.64-52.07-98.79-43.91-80.70
Sale Or Maturity of Investments60.1340.3437.6815.7140.1065.6650.8581.0338.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities17.94-6.17-8.138.628.4613.69-49.5628.18-43.85
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.560.560.670.753.9812.1188.2830.1492.88
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.560.560.670.753.9812.1188.2830.1492.88
Proceedsfrom Stock Options0.560.560.670.753.9812.1188.2830.1492.88
Issuance or Reduction of Debt, Net8.51-0.334.309.920.2121.183.5013.35-0.13
Change in Long Term Debt0.000.005.004.830.0015.000.008.33-0.13
Issuance of Long Term Debt0.000.005.004.830.0015.000.0039.430.00
Reduction of Long Term Debt0.000.000.000.000.000.000.00-31.10-0.13
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.00-0.00-0.00
Cash from Financing Activities-20.940.234.9610.674.1933.2991.7843.4992.75
Exchange Rate Effect-0.170.34-0.19-0.13-0.73-0.92---
Net Change in Cash0.17-0.768.00-24.00-13.6912.141.485.8317.66
Free Cash Flow0.331.118.52-47.77-27.61-34.83-42.36-74.77-32.39
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow1,463.21354.3533.35------
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments57.1156.2680.4282.8878.5178.03
Short Term Receivables30.5630.9829.3230.3729.7731.39
Inventories64.6965.8161.1256.1053.1454.53
Other Current Assets4.214.264.475.035.704.59
Total Current Assets156.57157.31175.34174.38167.13168.53
Net Property, Plant & Equipment18.2218.3318.7019.3314.6615.56
Total Investments and Advances0.620.630.630.641.141.14
Intangible Assets1.321.321.321.321.321.32
Other Assets28.0027.6126.9226.1930.9426.52
Total Assets204.73205.19222.91221.86215.19213.07
Short Term Debt Incl. Current Port. of LT Debt31.8233.3455.5446.2538.8630.73
Accounts Payable25.6633.5231.7928.0125.4730.52
Other Current Liabilities22.5318.9420.0526.5524.1023.11
Total Current Liabilities80.0185.79107.38100.8088.4384.36
Long Term Debt43.1543.4641.8250.7059.3268.17
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities5.225.225.425.395.224.37
Total Liabilities128.37134.47154.62156.89152.98156.90
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity75.7070.0267.5564.2261.4655.43
Total Shareholders Equity75.7070.0267.5564.2261.4655.43
Accumulated Minority Interest0.660.690.730.740.740.74
Total Equity76.3670.7268.2964.9762.2056.17
Total Liabilities & Stockholders Equity204.73205.19222.91221.86215.19213.07
Book Value Per Share0.370.350.340.330.320.29
Tangible Book Value Per Share0.370.340.330.330.310.28
Full-Time Employees---275--
Price to Book Ratio5.658.665.456.445.504.86
Return on Assets-3.48-3.24-4.45-7.39-7.89-9.47
Return on Equity-10.66-10.81-15.52-25.97-27.78-35.98
Return on Invested Capital-0.46-2.59-1.50-1.90-0.02-4.62
Quick Ratio1.151.071.061.171.291.35
Current Ratio1.961.831.631.731.892.00

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-0.58-2.98-1.65-2.18-0.02-5.71
Depreciation0.420.460.450.390.380.34
Other Funds (Non Cash)7.045.955.505.775.886.34
Funds from Operations6.883.434.303.986.240.97
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-3.87-6.27-7.352.22-4.31-3.42
Cash from Operating Activities3.02-2.84-3.056.201.93-2.45
Capital Expenditures-0.59-0.87-0.23-1.31-1.83-0.48
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-2.8213.7410.09-0.07-0.68-0.61
Purchase of Investments-15.23-0.53-8.41-15.01-7.29-12.51
Sale Or Maturity of Investments12.4214.2718.5014.946.6111.90
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-3.4112.879.86-1.38-2.51-1.09
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.35-0.060.260.000.32-0.03
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.35-0.060.260.000.32-0.03
Proceedsfrom Stock Options0.35-0.060.260.000.32-0.03
Issuance or Reduction of Debt, Net-1.5810.190.93-1.03-0.00-0.10
Change in Long Term Debt0.00-0.930.930.000.000.00
Issuance of Long Term Debt0.00-0.930.930.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-1.24-19.861.19-1.030.32-0.13
Exchange Rate Effect-0.00-0.04-0.120.00-0.060.21
Net Change in Cash-1.63-9.877.883.79-0.32-3.45
Free Cash Flow2.43-3.71-3.284.890.09-2.92
Price to Free Cash Flow1,463.21--357.171,815.5378.80

Revenue breakdown

Government Contract2024: 21.05M 2025: 27.67M
Product2024: 180.27M 2025: 206.13M
France2024: 19.69M 2025: 21.20M
Other Countries2024: 51.32M 2025: 60.21M
United States2024: 130.31M 2025: 152.39M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-307.66%14.6M191.1M2.11M
2026-10-158.72%16.6M190.7M2.17M
2026-09-309.22%17.6M190.7M2.29M
2026-09-159.44%18.0M190.7M2.44M
2026-08-319.29%17.7M190.7M2.63M
2026-08-149.09%17.3M190.6M2.77M
2026-07-317.85%15.0M190.6M2.99M
2026-07-157.22%13.7M189.5M2.72M
2026-06-306.72%12.7M189.5M2.45M
2026-06-1510.20%19.7M193.1M2.23M
2026-05-295.57%10.8M193.2M2.32M
2026-05-159.58%18.5M193.3M2.17M
2026-04-305.96%11.3M189.1M1.53M
2026-04-156.18%11.2M181.3M1.55M
2026-03-316.07%11.1M183.1M1.73M
2026-03-135.74%10.5M183.1M1.65M
2026-02-274.25%7.8M183.1M1.44M
2026-02-134.27%7.8M183.0M1.43M
2026-01-303.68%6.7M183.0M1.50M
2026-01-153.90%7.1M183.0M1.49M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.501.002.002.1219.6954.000.000.967-0.0100.000
call1.000.601.601.3511.45011.000.000.899-0.0200.001
call1.500.101.100.657.07430.000.000.819-0.0170.001
call2.000.000.600.453.45630.000.000.635-0.0140.001
call3.000.000.550.101.9751,1140.000.165-0.0090.001
call4.000.000.050.032.8963170.000.125-0.0110.001
call5.000.000.750.003.6260.000.000.108-0.0130.001
call6.000.000.100.104.13413.000.000.099-0.0130.001
put0.500.000.050.366.6813.000.00-0.037-0.0090.000
put1.000.001.000.005.9740.000.00-0.101-0.0200.001
put1.500.001.000.053.4892.000.00-0.181-0.0170.001
put2.000.000.300.201.61110.000.00-0.365-0.0140.001
put3.000.451.200.704.3592.000.00-0.835-0.0090.001
put4.001.552.551.308.2581.000.00-0.875-0.0110.001
put5.002.503.500.008.7240.000.00-0.892-0.0120.001
put6.003.504.500.009.3710.000.00-0.901-0.0130.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-02S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-11-0210-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-028-KCurrent report2026-11-02SEC
2026-08-17144Filing for proposed sale of securities under Rule 144.SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-17SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-13SCHEDULE 13G/ASEC
2026-07-30S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-07-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-308-KCurrent report2026-07-30SEC
2026-07-204Statement of changes in beneficial ownership of securities2026-07-16SEC
2026-07-16144Filing for proposed sale of securities under Rule 144.SEC
2026-07-108-KCurrent report2026-07-06SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-09144Filing for proposed sale of securities under Rule 144.SEC
2026-06-088-KCurrent report2026-06-05SEC
2026-06-038-KCurrent report2026-06-02SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-05-29144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080089.53K1
2026-070052.66K1
2026-0600648.48K5
2026-0500100.00K2
2026-040000
2026-03002.10M12
2026-020000
2026-010000
2025-120000
2025-110093.50K1

Institutional holders

Manager% owned
BlackRock, Inc.11.09%
ARK Investment Management LLC8.95%
VANGUARD CAPITAL MANAGEMENT LLC4.27%
MACKENZIE FINANCIAL CORP3.24%
BAKER BROS. ADVISORS LP3.19%
D. E. Shaw & Co., Inc.2.74%
ACADIAN ASSET MANAGEMENT LLC2.47%
STATE STREET CORP2.37%
GEODE CAPITAL MANAGEMENT, LLC2.34%
Senvest Management, LLC2.30%

Funds

Fund% owned
ARK Innovation ETF4.13%
ARK Genomic Revolution ETF3.60%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.03%
iShares Russell 2000 ETF2.59%
Wasatch Ultra Growth Fund1.60%
VANGUARD EXTENDED MARKET INDEX FUND1.15%
Fidelity Small Cap Index Fund1.09%
iShares Russell 2000 Growth ETF0.93%
Wasatch Micro Cap Value Fund0.76%
BlackRock Advantage Small Cap Core Fund0.76%

OakChart. CERS. Cached 15 minutes.